You Are Invited to a Complimentary CME/CE Symposium

In spite of the increasing prevalence and incidence of gout, its impact is clinically underappreciated. Approaches to treating gout in rheumatology practice vary, in part because there is currently very little evidence-based guidance. The current challenges to optimal management include limited understanding of the pathophysiology of hyperuricemia, crystal deposition, and progression into advanced disease. Furthermore, gout management across health care specialties often does not address comorbidities prevalent in these patients. A thorough assessment of the available treatment options, including the newest agents, may benefit the overall management of the individual patient with advanced crystal deposition.

This symposium will consist of didactic lectures by rheumatology experts, who will discuss how to best address these challenges and allow for rheumatology clinicians to best consider the latest data and advances in diagnosis and treatment for chronic, advanced gout. Each brief lecture will be followed by an expert panel discussion with question and answer sessions.

This symposium is jointly sponsored by Interstate Postgraduate Medical Association and MedEdRules, LLC and is supported by a grant from Savient Pharmaceuticals, Inc. This is not an official program of the American College of Rheumatology.